ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Mouse Models, Lupus"

  • Abstract Number: 0017 • ACR Convergence 2023

    Xist Ribonucleoproteins Promote Female Sex-biased Autoimmunity

    Diana Dou1, Yanding Zhao1, Julia Belk1, Yang Zhao1, Kerriann Casey2, Derek Chen1, Rui Li1, Bingfei Yu1, Suhas Srinivasan1, Brian Abe1, Katerina Kraft1, Ceke Hellström3, Ronald Sjöberg4, Sarah Chang5, Allan Feng5, Daniel Goldman6, Ami Shah7, Michelle Petri6, Lorinda Chung8, David Fiorentino9, Emma Lundberg10, Anton Wutz11, Paul Utz5 and Howard Chang1, 1Center for Personal Dynamic Regulomes and Program in Epithelial Biology, Department of Dermatology, Stanford University School of Medicine, Stanford, CA, 2Department of Comparative Medicine, Stanford University, Stanford, CA, 3Autoimmunity and Serology Profiling, Division of Affinity Proteomics, Department of Protein Science, KTH Royal Institute of Technology, SciLifeLab, Stockholm, Sweden, 4Department of Protein Science, SciLifelab, KTH Royal Institute of Technology, Stockholm, Sweden, 5Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 6Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Timonium, MD, 7Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Ellicott City, MD, 8Department of Medicine, Division of Immunology and Rheumatology, Stanford University School of Medicine, Woodside, CA, 9Department of Dermatology, Stanford University School of Medicine, Menlo Park, CA, 10Departments of Bioengineering and Pathology, Stanford University, Stanford, CA, 11Department of Biology, Institute of Molecular Health Sciences, Swiss Federal Institute of Technology, ETH Hönggerberg, Zurich, Switzerland

    Background/Purpose: Autoimmune diseases disproportionately affect females more than males. The XX sex chromosome complement is strongly associated with susceptibility to autoimmunity. Xist long noncoding RNA…
  • Abstract Number: 0599 • ACR Convergence 2023

    Targeted Inhibition of Cathepsins Limits the Intracellular Complement Activation in Lupus Nephritis Podocytes

    Ana Kunzler1, Meenakshi Jha1, Masataka Umeda2, Rhea Bhargava2, Maria Tsokos1, George Tsokos2 and Abhigyan Satyam2, 1Beth Israel Deaconess Medical Center, Boston, MA, 2Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Background/Purpose: Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease that leads to damage to several tissues and organs. Inflammation of the kidney is one…
  • Abstract Number: 1665 • ACR Convergence 2022

    The TLR7/8 Inhibitor Enpatoran Reverses Established Kidney Disease in the Interferon-Alpha-Accelerated NZB/W Mouse Model of Lupus

    Julia Bruttger1, Andrew Bender2, Sonja Reissig1, Amy Kao3 and Philipp Haselmayer1, 1the healthcare business of Merck KGaA, Darmstadt, Germany, 2TIP Immunology, EMD Serono, Billerica, MA, 3EMD Serono, Billerica, MA

    Background/Purpose: Activation of toll-like receptor 7 and 8 (TLR7/8) signaling by single-stranded RNA results in immune cell stimulation and inflammatory cytokine production, a normal circumstance…
  • Abstract Number: 1666 • ACR Convergence 2022

    Differentiation of Injury-associated Macrophages in Lupus Kidneys Is Conserved in Humans and Lupus Mouse Models

    Paul Hoover1, David Lieb2, Stephen Li2, Chirag Raparia3, Accelerating Medicines Partnership SLE/RA4, Arnon Arazi5, Nir Hacohen2 and Anne Davidson6, 1Brigham and Women's Hospital, Boston, MA, 2Broad Institute, Cambridge, MA, 3Donald and Barbara Zucker School of Medicine At Hofstra/Northwell, Shoreham, NY, 4NIH, Bethesda, MD, 5Feinstein Institutes for Medical Research, Melrose, MA, 6Feinstein Institutes for Medical Research, Manhasset, NY

    Background/Purpose: Infiltrating monocytes acquire functions that support kidney remodeling in response to tissue damage in lupus nephritis. This process of monocyte differentiation has been difficult…
  • Abstract Number: 1698 • ACR Convergence 2022

    LINE1 Reverse Transcriptase Inhibitors Abrogate Type 1 Interferon Responses

    Daniel Rios1, Nafeeza Hafeez1, Brian Desrosiers1, Shradha Rao1, Jess Floro1, Joelle Baddour1, Nisha Perez2, Greg Bisacchi2, Oliver Saunders2, Donna Romero1, Menachem Fromer2, Enrique Garcia-Rivera2, Wilson McKerrow2, Julie Behr2, Bryan Thornlow2, Dennis Zaller2, David Proia2 and Wenyan Miao2, 1Rome Therapeutics, Cambridge, MA, 2Rome Tx, Cambridge, MA

    Background/Purpose: Transposable elements (TEs) are mobile DNA elements that can replicate and move from one position to another within the host genome. Through co-evolution, TEs…
  • Abstract Number: 1707 • ACR Convergence 2022

    Exploring the Role of Lipocalin-2 in Neuropsychiatric SLE

    Chaim Putterman1, Sayra Garcia-Murillo2 and Elise Mike3, 1Albert Einstein College of Medicine, Bronx, NY, 2Albert Einstein College of Medicine, New York, NY, 3John Hopkins University, Baltimore, MD

    Background/Purpose: While the etiology of neuropsychiatric lupus (NPSLE) is not fully understood, blood brain barrier (BBB) disruption and localized neuroinflammation are potential mechanisms that contribute…
  • Abstract Number: 1710 • ACR Convergence 2022

    CCL2 Drives Interferon-enhanced Monocytosis in UV-mediated Skin Injury in Murine Lupus

    Mitra Maz1, Hong Shi2, Sonya Wolf-Fortune3, Shannon Estadt3, Alayka Reddy3, Rachael Wasikowski3, Alex Tsoi3, Celine Berthier3 and J. Michelle Kahlenberg3, 1University of Michigan Medical School, Ann Arbor, MI, 2Department of Internal Medicine/Division of Rheumatology, Vascular Biology Center, Augusta, GA, 3University of Michigan, Ann Arbor, MI

    Background/Purpose: Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by overproduction of type I interferons (IFNs) and sensitivity to ultraviolet (UV) light. Though…
  • Abstract Number: 1712 • ACR Convergence 2022

    The Lymph Node Microenvironment in SLE Mice Is Altered and Impairs Egress of T Lymphocytes

    Mir Howlader1, Audrey Baeyens2, Susan Schwab2 and theresa Lu3, 1Weill Cornell Medical College, Brooklyn, NY, 2New York University Grossman School of Medicine, New York, NY, 3Hospital for Special Surgery, New York, NY

    Background/Purpose: T cell entry into and exit from lymph nodes (LNs) exposes T cells to antigens/cytokines required for their activation and regulates the nature of…
  • Abstract Number: 1713 • ACR Convergence 2022

    Bank1 Signaling Shapes the Gut Microbiota Composition by Controlling the Gut Mucosal B-cell Response in Lupus

    Georgina Galicia-Rosas, María Botía Sánchez, Daniel Toro-Domínguez, Lorena Albadalejo and Marta Alarcon-Riquelme, Center for Genomics and Oncological Research (GENYO), Granada, Spain

    Background/Purpose: Mucosa-associated commensal bacteria have been shown to be involved in the pathogenesis of systemic lupus erythematosus (SLE). However, its exact role remains to be…
  • Abstract Number: 1716 • ACR Convergence 2022

    The Transcriptomic Landscape of Nephritic Kidneys Reveals Mechanisms for End Organ Resistance to Damage in Lupus-prone Mice

    Andrea Daamen1, Hongyang Wang2, Prathyusha Bachali3, Shu Man Fu2, Amrie Grammer4 and Peter Lipsky1, 1AMPEL BioSolutions, Charlottesville, VA, 2University of Virginia, Charlottesville, VA, 3AMPEL BioSolutions, Redmond, WA, 4AMPEL LLC, Charlottesville, VA

    Background/Purpose: Pathologic inflammation is a major driver of kidney damage in lupus nephritis (LN), but the immune mechanisms of disease progression and risk factors for…
  • Abstract Number: 1717 • ACR Convergence 2022

    Deficiency of IL-23 Receptor in Podocytes of MRL/lpr lupus-prone Mice Abrogates the Development of Lupus Nephritis Despite IgG Deposition in the Glomeruli

    Afroditi Boulougoura1, Hao Li1, Rhea Bhargava1, Wenliang Pan1, Abhigyan Satyam1, Isaac Stillman2 and George Tsokos1, 1Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, 2Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

    Background/Purpose: Interleukin 23 (IL-23) is involved in the pathogenesis of systemic lupus erythematosus (SLE). IL-23 is elevated in the sera of patients with active SLE…
  • Abstract Number: 1718 • ACR Convergence 2022

    Parenchymal INFγ Response Regulates Murine Lupus Nephritis

    Minjung Kim1, Anthony Marinov1, Mark Shlomchik2 and Jeremy Tilstra2, 1University of Pittsburgh, Pittsburgh, 2University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Lupus nephritis is the most common life-threatening end-organ complication of SLE. Interstitial infiltrates, specifically T cells, are major predictors of disease outcomes. We recently…
  • Abstract Number: 1720 • ACR Convergence 2022

    FASlpr Gene Dosage Differentiates Lymphoproliferative from Non-lymphoproliferative Autoimmunity – a Novel Mouse Model of Lupus

    Ritu Bohat1, Chunyu Xu1, Xiaofang Liang1, Yanping Chen1, Ningbo Zheng1, Roshni Jaffery1, Ashley Guerrero1, Nicholas Egan1, John Hicks2, Chandra mohan1 and Weiyi Peng1, 1University of Houston, Houston, TX, 2Baylor College of Medicine, Houston, TX

    Background/Purpose: Sle1 and FASlpr are two lupus susceptibility loci that lead to manifestations of systemic lupus erythematosus (SLE) by altering the FAS/FASL pathway and adaptive…
  • Abstract Number: 1725 • ACR Convergence 2022

    Sex Differences in Autoimmune Pathogenesis and Systemic Response to High Fat Diet in Lupus-prone Mice

    Gitanjali Lobo1, Juan Meng2, Xuhua Shi2, Ronak Patel3, Laura Rivers4, Chad Hille5, Robert Quinet6, William Davis7, Jerald Zakem8, Chandana Keshavamurthy9, Tamika Webb-Detiege10, Zongbing You2 and Xin Zhang11, 1Ochsner Clinic Foundation, Metairie, LA, 2Tulane University, New Orleans, LA, 3Ochsner, New Orleans, LA, 4Ochsner Medical Center, River Ridge, LA, 5Ochsner Clinic Foundation, New Orleans, LA, 6Ochsner Health, River Ridge, LA, 7Ochsner Medical Center, New Orleans, LA, 8Ochsner Health Systems, Metairie, LA, 9ochsner medical center, Metairie, LA, 10University of Queensland/Ochsner Clinical School, New Orleans, LA, 11Institution of Translational Research, Ochsner Health System, New Orleans, LA

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by chronic inflammation and the production of autoantibodies, leading to systemic multiorgan damage. SLE has…
  • Abstract Number: 1726 • ACR Convergence 2022

    Impaired Dynamic X-Chromosome Inactivation Maintenance in T Lymphocytes Is a Feature of Spontaneous Lupus in Female Mice and Is Exacerbated in Female-Biased Disease Models

    Nikhil Jiwrajka1, Natalie Toothacre2, Zachary Beethem2, Sarah Sting2, Katherine Forsyth2, Amanda Driscoll2, William Stohl3 and Montserrat Anguera2, 1Division of Rheumatology, Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 2Department of Biomedical Sciences, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA, 3University of Southern California, Los Angeles, CA

    Background/Purpose: SLE is highly female-biased, yet the molecular origins of this bias remain unclear. The X chromosome contains many immune-related genes, suggesting that X-linked epigenetic…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology